EXCELLOS
Developer and manufacturer of cell and gene therapies intended to facilitate the advancement of advanced therapies. The company offers development and clinical manufacturing for CAR-T, tumor-infiltrating lymphocyte therapy and immunotherapy, enabling clients to realize the potential of these powerful therapeutics and helps in saving patients' lives. They focus on providing cGMP cellular products and services to scientists and physicians working with cell and gene therapies, as well as process development and manufacturing expertise. The mission is to accelerate the development of cellular therapies and to enable these powerful medications to reach their full potential, saving lives now and improving lives tomorrow. establishing a new benchmark in the industry.
EXCELLOS
Industry:
Advanced Materials Alternative Medicine Biotechnology Health Care Life Science Medical Product Research
Founded:
2021-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.excellos.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
15 M USD
Similar Organizations
DermResearch
DermResearch is a leading dermatology research center in the United States.
RIKO-med
RIKO-med is an official developer and manufacturer of reagent kits for neonatal screening.
Vancouver Prostate Centre
VPC is a outpatient clinic and in-house research center.
Investors List
Telegraph Hill Partners
Telegraph Hill Partners investment in Funding Round - Excellos
Official Site Inspections
http://www.excellos.com Semrush global rank: 5.9 M Semrush visits lastest month: 1.4 K
- Host name: 45.32.82.91.vultrusercontent.com
- IP address: 45.32.82.91
- Location: Los Angeles United States
- Latitude: 34.0729
- Longitude: -118.2606
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90012
More informations about "Excellos"
About Excellos - Excellos
Virginia Bunnell leads the people strategy for Excellos, including developing a high-performance culture that motivates and drives alignment of organization goals and initiatives. She is …See details»
Cell and Gene Therapy Industry - Excellos
Jan 25, 2022 Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank. Cell and Gene Therapy CDMO. San Diego, CA: Excellos, Incorporated, a cell therapy Contract …See details»
Excellos - Crunchbase Company Profile & Funding
Excellos is a developer and manufacturer of cell and gene therapies intended to facilitate the advancement of advanced therapies. The company offers development and clinical manufacturing for CAR-T, tumor-infiltrating …See details»
Excellos Launches to Accelerate Innovation in the Cell …
Jan 25, 2022 SAN DIEGO--(BUSINESS WIRE)--Excellos, Incorporated, a cell therapy Contract Development and Manufacturing Organization (CDMO), announces its official corporate launch and closing of $15M in growth ...See details»
Excellos Company Profile 2024: Valuation, Funding & Investors
Excellos General Information Description. Developer of cell and gene therapy technology designed to facilitate the advancement of cell and gene therapies. The company's technology …See details»
Excellos Announces Acceleration of Commercialization, …
May 7, 2024 New investment funds expansion of commercial team. SAN DIEGO, May 07, 2024--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today ...See details»
Excellos launches as cell therapy CDMO - BioProcess …
Jan 25, 2022 A new contract development and manufacturing organization (CDMO) has arisen in San Diego, California this week: Excellos Incorporated, which officially launched on the back of $15 million in growth funding from …See details»
TC BioPharm Selects Excellos as CDMO in Anticipation of …
Oct 25, 2023 Excellos' proprietary Excellos 360 technology provides deep characterization of cells to better match patient with therapeutic development needs. About TC BioPharm …See details»
Excellos - Overview, News & Similar companies | ZoomInfo.com
May 6, 2024 Excellos Announces Strategic Partnership and Investment from Vitalant SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development …See details»
Thomas VanCott joins Excellos as new CEO
May 7, 2024 Excellos Announces Acceleration of Commercialization, New CEO, Thomas VanCott. New investment funds expansion of commercial team. SAN DIEGO. CA, May 7, 2024, – Excellos Inc., a cell therapy contract and …See details»
Excellos launches to advance cell and gene therapies
Jan 26, 2022 Excellos launches to advance cell and gene therapies By The Science Advisory Board staff writers. January 26, 2022-- Excellos, a cell therapy contract development and …See details»
Excellos Launches to Accelerate Innovation in the Cell and Gene …
Jan 25, 2022 Founded by an Experienced Management Team and Built on the Reach and Infrastructure of the San Diego Blood Bank January 24, 2022 San Diego, CA: Excellos, …See details»
Excellos Announces Strategic Partnership and Investment from …
Jan 17, 2024 SAN DIEGO--(BUSINESS WIRE)--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced a new partnership with …See details»
Excellos Launches as Latest Cell and Gene Therapy CDMO with $15M
SAN DIEGO, January 25, 2022 — Excellos, Incorporated, a cell therapy Contract Development and Manufacturing Organization (CDMO), announces its official corporate launch and closing …See details»
Excellos Selected as Decentralized Manufacturing Unit to Support ...
SAN DIEGO, October 01, 2024--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO) member of Blood Centers of America (BCA), today …See details»
Excellos Announces Strategic Partnership and Investment from …
SAN DIEGO, January 17, 2024--Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced a new partnership with Vitalant, one of …See details»
News - Excellos
Excellos Announces Acceleration of Commercialization, New CEO, Thomas VanCott New investment funds expansion of commercial team SAN DIEGO. CA, May 7, 2024, – Excellos …See details»
Excellos Selected as Decentralized Manufacturing Unit to ... - Nasdaq
Oct 1, 2024 Excellos Inc., a cell therapy contract and development manufacturing organization member of Blood Centers of America, today announced that it has been selected to …See details»